These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38258131)

  • 21. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
    Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
    Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of Tryptamine Derivatives as Multi-Target Directed Ligands for Alzheimer's Disease: AChE, MAO-B, and COX-2 as Molecular Targets.
    Asghar S; Mushtaq N; Ahmed A; Anwar L; Munawar R; Akhtar S
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38276568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blockers' contribution to overcoming Current drug discovery challenges in Alzheimer's disease.
    Bernard PJ; Bellili D; Ismaili L
    Expert Opin Drug Discov; 2024; 19(1):21-32. PubMed ID: 37800853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease.
    Ismaili L; do Carmo Carreiras M
    Curr Top Med Chem; 2017; 17(31):3319-3327. PubMed ID: 29332584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer's disease.
    Hu J; An B; Pan T; Li Z; Huang L; Li X
    Bioorg Med Chem; 2018 Nov; 26(21):5718-5729. PubMed ID: 30385227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
    Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
    Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
    Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
    Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond.
    Bolognesi ML; Rosini M; Andrisano V; Bartolini M; Minarini A; Tumiatti V; Melchiorre C
    Curr Pharm Des; 2009; 15(6):601-13. PubMed ID: 19199985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy.
    Perone R; Albertini C; Uliassi E; Di Pietri F; de Sena Murteira Pinheiro P; Petralla S; Rizzardi N; Fato R; Pulkrabkova L; Soukup O; Tramarin A; Bartolini M; Bolognesi ML
    ChemMedChem; 2021 Jan; 16(1):187-198. PubMed ID: 32716144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
    Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
    Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel dihydropyridine with 3-aryl meta-hydroxyl substitution blocks L-type calcium channels in rat cardiomyocytes.
    Galvis-Pareja D; Zapata-Torres G; Hidalgo J; Ayala P; Pedrozo Z; Ibarra C; Diaz-Araya G; Hall AR; Vicencio JM; Nuñez-Vergara L; Lavandero S
    Toxicol Appl Pharmacol; 2014 Aug; 279(1):53-62. PubMed ID: 24844443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.
    Wang M; Fang L; Liu T; Chen X; Zheng Y; Zhang Y; Chen S; Li Z
    Chem Biol Interact; 2021 Jun; 342():109489. PubMed ID: 33905740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.
    Mao F; Yan J; Li J; Jia X; Miao H; Sun Y; Huang L; Li X
    Org Biomol Chem; 2014 Aug; 12(31):5936-44. PubMed ID: 24986600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.
    Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z
    Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis, Calculation and Biological Activity Studies Based on Privileged Coumarin Derivatives as Multifunctional Anti-AD Lead Compound.
    Wang H; Su M; Shi X; Li X; Zhang X; Yang A; Shen R
    Chem Biodivers; 2023 Jan; 20(1):e202200867. PubMed ID: 36461922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
    Kumar A; Tiwari A; Sharma A
    Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.
    Sang Z; Wang K; Han X; Cao M; Tan Z; Liu W
    ACS Chem Neurosci; 2019 Feb; 10(2):1008-1024. PubMed ID: 30537804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.